Skip to content

Filtryzer Dialyzer, Capillary, Hollow Fiber

by Toray Industries (America), Inc.

510(k) K935471

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

2 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 5 Oct 2026. What this means

Regulatory status

as of registry sync 5 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK935471 Date19 May 1995ClearedStatusActive

Recalls

2 recalls · FDA

  • 2 recalls, same reason

    • Terminated Z-0351-04 FDA Unclassified (pre-2012) initiated 30 Dec 2003
    • Terminated Z-0349-04 FDA Unclassified (pre-2012) initiated 30 Dec 2003

    Potential loose header (end cap) on hollow fiber dialyzers.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Filtryzer(Tm)
510(k) Number
FDA Product Code
FJI
Device Class
Class II
Regulation
21 CFR Part 876.5820
Advisory Committee
Gastroenterology, Urology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Filtryzer is a Dialyzer, Capillary, Hollow Fiber, a medical device designed for hemofiltration and related extracorporeal blood purification therapies. It employs a semipermeable hollow fiber membrane to filter blood by removing waste products, excess fluids, and electrolytes, commonly used in critical care settings for patients with acute or chronic renal failure.

This device is supplied as a single-use, sterile disposable and is intended for use in controlled clinical environments such as dialysis units or intensive care settings. It is classified under FDA product code FJI and has received FDA 510K clearance (K935471) under the Traditional pathway, with regulatory oversight for Gastroenterology and Urology applications. Storage and handling must adhere to manufacturer guidelines to maintain sterility and functionality.

Other devices from Toray Industries (America), Inc.

See all devices from Toray Industries (America), Inc. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Filtryzer used for in medical treatments?

    The Filtryzer is a hollow fiber dialyzer designed specifically for hemofiltration and related extracorporeal blood purification therapies. It filters blood by removing waste products, excess fluids, and electrolytes, making it essential for patients with acute or chronic renal failure in critical care settings like dialysis units or intensive care units.

  • Is the Filtryzer intended for single-use or reuse?

    The Filtryzer is supplied as a single-use, sterile disposable device. This design ensures patient safety and sterility, as reuse could compromise the integrity of the semipermeable membrane and introduce contamination risks.

  • What regulatory pathway and clearance does the Filtryzer follow?

    The Filtryzer received FDA 510K clearance (K935471) under the Traditional pathway, with regulatory oversight for Gastroenterology and Urology applications. It is classified under FDA product code FJI and is substantially equivalent to its predicate device.

  • How should the Filtryzer be stored to maintain functionality?

    The Filtryzer must be stored and handled according to the manufacturer’s guidelines to preserve sterility and functionality. Proper storage conditions prevent damage to the hollow fiber membrane and ensure the device remains effective for its intended use in controlled clinical environments.

  • What types of clinical environments use the Filtryzer?

    The Filtryzer is intended for use in controlled clinical settings such as dialysis units and intensive care units. These environments ensure proper handling, sterility, and adherence to medical protocols required for hemofiltration therapies.